Viewing Study NCT06634394


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2026-01-04 @ 4:10 AM
Study NCT ID: NCT06634394
Status: RECRUITING
Last Update Posted: 2025-05-11
First Post: 2024-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Sponsor: Aptevo Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module